Cloud-based platform
Our SaaS solution utilizes a cloud-based platform to perform cancer tumor burden monitoring on a global scale, leveraging the thousands of already installed genome sequencers around the world.
Utilizing our platform, our technology is accessible anywhere in the world, bringing high precision personalized cancer monitoring to a growing number of locations on the map.
-
12
WORLDWIDE SITES
-
6
ACTIVE STUDIES
-
1,000
SAMPLES PROCESSED